Here in the Central Okanagan, industry-leading companies can be found in a multitude of sectors, including the booming cannabis industry. Having received its Nursery Cultivation licence from Health Canada in 2021, Kelowna-based Klonetics is one of those companies, offering an extensive selection of proprietary cannabis strains that medical growers and licensed producers can use to increase revenues.
“Klonetics has a portfolio of in-demand cannabis strains and will provide licensed producers and growers with plantlets or Ready to Flower™ plants, resulting in increased crop yields and higher quality genetics,” says the company’s CEO, David Brough. “We will be the premier cannabis cloning company that is cultivating in Canada.”
Once they reach full capacity in 2022, Klonetics will employ 50 people and produce nearly four million Ready to Flower™ plants out of its almost 25,000 square foot Kelowna facility, where each room is sealed and ventilated to the highest Goods Manufacturing Practice (GMP) standards.
The Klonetics team is made up of world-class specialists who have access to the best technology in the field.
“We did consider multiple locations throughout Canada; after comprehensive due diligence, Kelowna provided us with the best opportunity to thrive,” says Brough. “We continue to attract the industry’s top scientific talent from all parts of Canada.”
Thanks to its partnerships with some of the most reputable breeders across the globe, Klonetics now offers the largest breeder-certified cannabis strain catalogue in the world to licensed Canadian producers.
Klonetics also partners with VEXSL, a transport company specializing in climate sensitive, high-risk and high-value controlled goods, to ensure its
products arrive intact.
Being recognized as a disruptor in the industry is how Klonetics defines success. The company’s existing accomplishments, coupled with the fact that they’re sourcing additional space to expand, leaves no question that they are already on their desired trajectory.